Kazumasa Hiroishi
Kawasaki, 2150026, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Assessment of colonic contents in patients with chronic constipation using MRI.
Journal: Journal of clinical biochemistry and nutrition
Published: October 03, 2017
Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 16, 2014
Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood.
Journal: Viral immunology
Published: September 12, 2013
Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study.
Journal: Molecular and clinical oncology
Published: August 22, 2013
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.
Journal: Cancer immunology, immunotherapy : CII
Published: June 01, 2013
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.
Journal: Journal of viral hepatitis
Published: August 07, 2012
Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.
Journal: Cancer gene therapy
Published: July 14, 2012
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 10, 2012
Lymphotropic hepatitis C virus has an interferon-resistant phenotype.
Journal: Journal of viral hepatitis
Published: March 13, 2012
Mechanism of HCV persistence
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: November 22, 2011
Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.
Journal: Oncology reports
Published: November 14, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026